Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by MJ Leibfried
Payer Management and Pricing Dynamics for Non-Oncology Pharmacy Benefit Orphan Drugs for Rare Diseases in the United States Launched 2004-2014
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Psy180 - Uk Health Technology Assessment of Orphan Drugs for Rare Oncology Versus Rare Disease: Does Orphan Designation Make Any Difference in Hta Process?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pricing and Reimbursement of Orphan Drugs: The Need for More Transparency
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
First International South Caucasian Conference on Rare Diseases and Orphan Drugs
European Journal of Pediatrics
Child Health
Pediatrics
Perinatology
Value and Payment for Oncology in the United States
Annales Pharmaceutiques Francaises
Pharmacology
Pharmaceutical Science
Payer and Pharmaceutical Manufacturer Considerations for Outcomes-Based Agreements in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pivotal Studies of Orphan Drugs Approved for Neurological Diseases
Annals of Neurology
Neurology
Trends in Approvals and Prices of Oncology Drugs in the United States (1990-2013)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Proposed Definition of Rare Diseases for China: From the Perspective of Return on Investment in New Orphan Drugs
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Prices Analysis of Osteoporosis Drugs Marketed in the United States (1988-2014)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
